These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31175645)

  • 1. Cancer Stem Cells: Concepts, Challenges, and Opportunities for Cancer Therapy.
    Lee MY; Giraddi RR; Tam WL
    Methods Mol Biol; 2019; 2005():43-66. PubMed ID: 31175645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
    Eun K; Ham SW; Kim H
    BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of the cancer stem cell niche and therapeutic strategies.
    Ju F; Atyah MM; Horstmann N; Gul S; Vago R; Bruns CJ; Zhao Y; Dong QZ; Ren N
    Stem Cell Res Ther; 2022 Jun; 13(1):233. PubMed ID: 35659296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cells and their niche in the progression of squamous cell carcinoma.
    Oshimori N
    Cancer Sci; 2020 Nov; 111(11):3985-3992. PubMed ID: 32888236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
    Yadav AK; Desai NS
    Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cancer stem cells and their niche: perspectives for future therapeutic targets and strategies.
    Zhao Y; Dong Q; Li J; Zhang K; Qin J; Zhao J; Sun Q; Wang Z; Wartmann T; Jauch KW; Nelson PJ; Qin L; Bruns C
    Semin Cancer Biol; 2018 Dec; 53():139-155. PubMed ID: 30081228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An alginate-based platform for cancer stem cell research.
    Qiao SP; Zhao YF; Li CF; Yin YB; Meng QY; Lin FH; Liu Y; Hou XL; Guo K; Chen XB; Tian WM
    Acta Biomater; 2016 Jun; 37():83-92. PubMed ID: 27109764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic cancer stem cells: A state or an entity?
    Hermann PC; Sainz B
    Semin Cancer Biol; 2018 Dec; 53():223-231. PubMed ID: 30130664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
    Katoh M
    Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The developing cancer stem-cell model: clinical challenges and opportunities.
    Vermeulen L; de Sousa e Melo F; Richel DJ; Medema JP
    Lancet Oncol; 2012 Feb; 13(2):e83-9. PubMed ID: 22300863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional interdependence of hematopoietic stem cells and their niche in oncogene promotion of myeloproliferative neoplasms: the 159th biomedical version of "it takes two to tango".
    Zhan H; Kaushansky K
    Exp Hematol; 2019 Feb; 70():24-30. PubMed ID: 30593829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy relevance.
    Najafi M; Mortezaee K; Ahadi R
    Life Sci; 2019 Aug; 231():116520. PubMed ID: 31158379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?
    Plaks V; Kong N; Werb Z
    Cell Stem Cell; 2015 Mar; 16(3):225-38. PubMed ID: 25748930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells.
    Melzer C; von der Ohe J; Lehnert H; Ungefroren H; Hass R
    Mol Cancer; 2017 Feb; 16(1):28. PubMed ID: 28148265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling of Cancer Stem Cell State Transitions Predicts Therapeutic Response.
    Sehl ME; Shimada M; Landeros A; Lange K; Wicha MS
    PLoS One; 2015; 10(9):e0135797. PubMed ID: 26397099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting the umbilical cord: Cancer stem cell-targeted therapeutics.
    Banik A; Sharma R; Chauhan A; Singh S
    Life Sci; 2022 Jun; 299():120502. PubMed ID: 35351466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cells and angiogenesis.
    Zhao Y; Bao Q; Renner A; Camaj P; Eichhorn M; Ischenko I; Angele M; Kleespies A; Jauch KW; Bruns C
    Int J Dev Biol; 2011; 55(4-5):477-82. PubMed ID: 21732274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An emerging role for cellular crosstalk in the cancer stem cell niche.
    Oshimori N; Guo Y; Taniguchi S
    J Pathol; 2021 Jul; 254(4):384-394. PubMed ID: 33634866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.